| related words |
| dacogen |
| nicvax |
| pulsys |
| thrombin |
| oracea |
| qutenza |
| isolagen |
| chemofx |
| testim |
| sts |
| costar |
| zfp |
| recombinant |
| prototype |
| telavancin |
| bla |
| anthrax |
| onrigin |
| vantas |
| skin |
|
| related documents |
| 927829--3/2/2006--NITROMED_INC |
| 1062216--3/28/2008--MEMORY_PHARMACEUTICALS_CORP |
| 1113481--2/29/2008--MEDICINES_CO_/DE |
| 875320--3/1/2007--VERTEX_PHARMACEUTICALS_INC_/_MA |
| 911326--3/16/2007--TRIMERIS_INC |
| 911326--3/10/2006--TRIMERIS_INC |
| 1113481--3/1/2007--MEDICINES_CO_/DE |
| 875320--2/11/2008--VERTEX_PHARMACEUTICALS_INC_/_MA |
| 1157601--3/11/2010--SYNTA_PHARMACEUTICALS_CORP |
| 879169--3/5/2010--INCYTE_CORP |
| 946840--3/2/2009--VIROPHARMA_INC |
| 879169--3/3/2009--INCYTE_CORP |
| 1113481--3/2/2009--MEDICINES_CO_/DE |
| 1157601--3/26/2009--SYNTA_PHARMACEUTICALS_CORP |
| 1113481--3/15/2006--MEDICINES_CO_/DE |
|
| related topics |
| {product, liability, claim} |
| {product, candidate, development} |
| {control, financial, internal} |
| {property, intellectual, protect} |
| {financial, litigation, operation} |
| {customer, product, revenue} |
| {provision, law, control} |
| {operation, international, foreign} |
| {cost, contract, operation} |
| {system, service, information} |
| {cost, regulation, environmental} |
| {acquisition, growth, future} |
| {condition, economic, financial} |
| {debt, indebtedness, cash} |
| {investment, property, distribution} |
| {interest, director, officer} |
| {cost, operation, labor} |
| {regulation, government, change} |
| {capital, credit, financial} |
| {personnel, key, retain} |
|